 | • レポートコード：MRC2012B1321 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Service & Software |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、リウマチ薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。リウマチ薬の種類別市場規模（疾患修飾性抗リウマチ薬、非ステロイド性抗炎症薬、コルチコステロイド、尿酸薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Takeda Pharmaceutical、Pfizer、Novartis、Sanofi、AbbVie、Genentech、Merck & Co.、Amgen、Janssen Biotech、Bristol-Myers Squibb Company、 ・地域別グローバル市場分析 2015年-2020年 ・リウマチ薬の北米市場（アメリカ、カナダ、メキシコ） ・リウマチ薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・リウマチ薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・リウマチ薬の南米市場（ブラジル、アルゼンチン） ・リウマチ薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：疾患修飾性抗リウマチ薬、非ステロイド性抗炎症薬、コルチコステロイド、尿酸薬、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Rheumatology Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rheumatology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rheumatology Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rheumatology Drugs market has been segmented into:
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others
By Application, Rheumatology Drugs has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rheumatology Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Rheumatology Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rheumatology Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Rheumatology Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Rheumatology Drugs Market Share Analysis
Rheumatology Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rheumatology Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rheumatology Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Rheumatology Drugs are:
Takeda Pharmaceutical
Pfizer
Novartis
Sanofi
AbbVie
Genentech
Merck & Co.
Amgen
Janssen Biotech
Bristol-Myers Squibb Company
Table of Contents
1 Rheumatology Drugs Market Overview
1.1 Product Overview and Scope of Rheumatology Drugs
1.2 Classification of Rheumatology Drugs by Type
1.2.1 Global Rheumatology Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rheumatology Drugs Revenue Market Share by Type in 2019
1.2.3 Disease Modifying Anti-rheumatic Drugs
1.2.4 Nonsteroidal Anti-inflammatory Drugs
1.2.5 Corticosteroids
1.2.6 Uric Acid Drugs
1.2.7 Others
1.3 Global Rheumatology Drugs Market by Application
1.3.1 Overview: Global Rheumatology Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Global Rheumatology Drugs Market by Regions
1.4.1 Global Rheumatology Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rheumatology Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rheumatology Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rheumatology Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rheumatology Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rheumatology Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rheumatology Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Takeda Pharmaceutical
2.1.1 Takeda Pharmaceutical Details
2.1.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Takeda Pharmaceutical SWOT Analysis
2.1.4 Takeda Pharmaceutical Product and Services
2.1.5 Takeda Pharmaceutical Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 AbbVie
2.5.1 AbbVie Details
2.5.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AbbVie SWOT Analysis
2.5.4 AbbVie Product and Services
2.5.5 AbbVie Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Genentech
2.6.1 Genentech Details
2.6.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Genentech SWOT Analysis
2.6.4 Genentech Product and Services
2.6.5 Genentech Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co.
2.7.1 Merck & Co. Details
2.7.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co. SWOT Analysis
2.7.4 Merck & Co. Product and Services
2.7.5 Merck & Co. Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Amgen SWOT Analysis
2.8.4 Amgen Product and Services
2.8.5 Amgen Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Janssen Biotech
2.9.1 Janssen Biotech Details
2.9.2 Janssen Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Janssen Biotech SWOT Analysis
2.9.4 Janssen Biotech Product and Services
2.9.5 Janssen Biotech Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb Company
2.10.1 Bristol-Myers Squibb Company Details
2.10.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Company SWOT Analysis
2.10.4 Bristol-Myers Squibb Company Product and Services
2.10.5 Bristol-Myers Squibb Company Rheumatology Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rheumatology Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rheumatology Drugs Players Market Share
3.2.2 Top 10 Rheumatology Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rheumatology Drugs Revenue and Market Share by Regions
4.2 North America Rheumatology Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Rheumatology Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rheumatology Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Rheumatology Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rheumatology Drugs Revenue and Growth Rate (2015-2020)
5 North America Rheumatology Drugs Revenue by Countries
5.1 North America Rheumatology Drugs Revenue by Countries (2015-2020)
5.2 USA Rheumatology Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Rheumatology Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Rheumatology Drugs Revenue and Growth Rate (2015-2020)
6 Europe Rheumatology Drugs Revenue by Countries
6.1 Europe Rheumatology Drugs Revenue by Countries (2015-2020)
6.2 Germany Rheumatology Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Rheumatology Drugs Revenue and Growth Rate (2015-2020)
6.4 France Rheumatology Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Rheumatology Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rheumatology Drugs Revenue by Countries
7.1 Asia-Pacific Rheumatology Drugs Revenue by Countries (2015-2020)
7.2 China Rheumatology Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Rheumatology Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Rheumatology Drugs Revenue and Growth Rate (2015-2020)
7.5 India Rheumatology Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
8 South America Rheumatology Drugs Revenue by Countries
8.1 South America Rheumatology Drugs Revenue by Countries (2015-2020)
8.2 Brazil Rheumatology Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Rheumatology Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rheumatology Drugs by Countries
9.1 Middle East & Africa Rheumatology Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Rheumatology Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Rheumatology Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Rheumatology Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rheumatology Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Rheumatology Drugs Market Forecast by Type (2019-2024)
10.3 Disease Modifying Anti-rheumatic Drugs Revenue Growth Rate (2015-2025)
10.4 Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2015-2025)
10.5 Corticosteroids Revenue Growth Rate (2015-2025)
10.6 Uric Acid Drugs Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Rheumatology Drugs Market Segment by Application
11.1 Global Rheumatology Drugs Revenue Market Share by Application (2015-2020)
11.2 Rheumatology Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacy Revenue Growth (2015-2020)
11.4 Retail Pharmacy Revenue Growth (2015-2020)
11.5 Online Pharmacy Revenue Growth (2015-2020)
12 Global Rheumatology Drugs Market Size Forecast (2021-2025)
12.1 Global Rheumatology Drugs Market Size Forecast (2021-2025)
12.2 Global Rheumatology Drugs Market Forecast by Regions (2021-2025)
12.3 North America Rheumatology Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Rheumatology Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rheumatology Drugs Revenue Market Forecast (2021-2025)
12.6 South America Rheumatology Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rheumatology Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Rheumatology Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rheumatology Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rheumatology Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rheumatology Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 6. Takeda Pharmaceutical Rheumatology Drugs Major Business
Table 7. Takeda Pharmaceutical Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Takeda Pharmaceutical SWOT Analysis
Table 9. Takeda Pharmaceutical Rheumatology Drugs Product and Solutions
Table 10. Takeda Pharmaceutical Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pfizer Corporate Information, Location and Competitors
Table 12. Pfizer Rheumatology Drugs Major Business
Table 13. Pfizer Rheumatology Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Pfizer SWOT Analysis
Table 15. Pfizer Rheumatology Drugs Product and Solutions
Table 16. Pfizer Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Rheumatology Drugs Major Business
Table 19. Novartis Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Rheumatology Drugs Product and Solutions
Table 22. Novartis Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sanofi Corporate Information, Location and Competitors
Table 24. Sanofi Rheumatology Drugs Major Business
Table 25. Sanofi Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Sanofi SWOT Analysis
Table 27. Sanofi Rheumatology Drugs Product and Solutions
Table 28. Sanofi Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AbbVie Corporate Information, Location and Competitors
Table 30. AbbVie Rheumatology Drugs Major Business
Table 31. AbbVie Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 32. AbbVie SWOT Analysis
Table 33. AbbVie Rheumatology Drugs Product and Solutions
Table 34. AbbVie Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Genentech Corporate Information, Location and Competitors
Table 36. Genentech Rheumatology Drugs Major Business
Table 37. Genentech Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Genentech SWOT Analysis
Table 39. Genentech Rheumatology Drugs Product and Solutions
Table 40. Genentech Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck & Co. Corporate Information, Location and Competitors
Table 42. Merck & Co. Rheumatology Drugs Major Business
Table 43. Merck & Co. Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Merck & Co. SWOT Analysis
Table 45. Merck & Co. Rheumatology Drugs Product and Solutions
Table 46. Merck & Co. Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Amgen Corporate Information, Location and Competitors
Table 48. Amgen Rheumatology Drugs Major Business
Table 49. Amgen Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Amgen SWOT Analysis
Table 51. Amgen Rheumatology Drugs Product and Solutions
Table 52. Amgen Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Janssen Biotech Corporate Information, Location and Competitors
Table 54. Janssen Biotech Rheumatology Drugs Major Business
Table 55. Janssen Biotech Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Janssen Biotech SWOT Analysis
Table 57. Janssen Biotech Rheumatology Drugs Product and Solutions
Table 58. Janssen Biotech Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 60. Bristol-Myers Squibb Company Rheumatology Drugs Major Business
Table 61. Bristol-Myers Squibb Company Rheumatology Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Bristol-Myers Squibb Company SWOT Analysis
Table 63. Bristol-Myers Squibb Company Rheumatology Drugs Product and Solutions
Table 64. Bristol-Myers Squibb Company Rheumatology Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Rheumatology Drugs Revenue (Million USD) by Players (2015-2020)
Table 66. Global Rheumatology Drugs Revenue Share by Players (2015-2020)
Table 67. Global Rheumatology Drugs Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Rheumatology Drugs Revenue Market Share by Regions (2015-2020)
Table 69. North America Rheumatology Drugs Revenue by Countries (2015-2020)
Table 70. North America Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Europe Rheumatology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Rheumatology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Rheumatology Drugs Revenue by Countries (2015-2020)
Table 74. South America Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Rheumatology Drugs Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Global Rheumatology Drugs Revenue (Million USD) by Type (2015-2020)
Table 78. Global Rheumatology Drugs Revenue Share by Type (2015-2020)
Table 79. Global Rheumatology Drugs Revenue Forecast by Type (2021-2025)
Table 80. Global Rheumatology Drugs Revenue by Application (2015-2020)
Table 81. Global Rheumatology Drugs Revenue Share by Application (2015-2020)
Table 82. Global Rheumatology Drugs Revenue Forecast by Application (2021-2025)
Table 83. Global Rheumatology Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rheumatology Drugs Picture
Figure 2. Global Rheumatology Drugs Revenue Market Share by Type in 2019
Figure 3. Disease Modifying Anti-rheumatic Drugs Picture
Figure 4. Nonsteroidal Anti-inflammatory Drugs Picture
Figure 5. Corticosteroids Picture
Figure 6. Uric Acid Drugs Picture
Figure 7. Others Picture
Figure 8. Rheumatology Drugs Revenue Market Share by Application in 2019
Figure 9. Hospital Pharmacy Picture
Figure 10. Retail Pharmacy Picture
Figure 11. Online Pharmacy Picture
Figure 12. Global Rheumatology Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Rheumatology Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Rheumatology Drugs Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Rheumatology Drugs Revenue Market Share in 2019
Figure 21. Global Top 10 Players Rheumatology Drugs Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Rheumatology Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Rheumatology Drugs Revenue Market Share by Regions (2015-2020)
Figure 25. Global Rheumatology Drugs Revenue Market Share by Regions in 2018
Figure 26. North America Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Europe Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 29. South America Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 31. North America Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 32. North America Rheumatology Drugs Revenue Market Share by Countries in 2019
Figure 33. USA Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Canada Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Europe Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Rheumatology Drugs Revenue Market Share by Countries in 2019
Figure 38. Germany Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 39. UK Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 40. France Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Russia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Italy Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Rheumatology Drugs Revenue Market Share by Countries in 2019
Figure 45. China Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Japan Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Korea Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 48. India Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 50. South America Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. South America Rheumatology Drugs Revenue Market Share by Countries in 2019
Figure 52. Brazil Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Rheumatology Drugs Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 57. UAE Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Rheumatology Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Global Rheumatology Drugs Revenue Share by Type (2015-2020)
Figure 61. Global Rheumatology Drugs Revenue Share by Type in 2019
Figure 62. Global Rheumatology Drugs Market Share Forecast by Type (2021-2025)
Figure 63. Global Disease Modifying Anti-rheumatic Drugs Revenue Growth Rate (2015-2020)
Figure 64. Global Nonsteroidal Anti-inflammatory Drugs Revenue Growth Rate (2015-2020)
Figure 65. Global Corticosteroids Revenue Growth Rate (2015-2020)
Figure 66. Global Uric Acid Drugs Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Rheumatology Drugs Revenue Share by Application (2015-2020)
Figure 69. Global Rheumatology Drugs Revenue Share by Application in 2019
Figure 70. Global Rheumatology Drugs Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospital Pharmacy Revenue Growth Rate (2015-2020)
Figure 72. Global Retail Pharmacy Revenue Growth Rate (2015-2020)
Figure 73. Global Online Pharmacy Revenue Growth Rate (2015-2020)
Figure 74. Global Rheumatology Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Rheumatology Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Rheumatology Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Rheumatology Drugs Revenue Market Forecast (2021-2025)
Figure 78. Europe Rheumatology Drugs Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Rheumatology Drugs Revenue Market Forecast (2021-2025)
Figure 80. South America Rheumatology Drugs Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Rheumatology Drugs Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
リウマチ治療の世界市場（～2026年） A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. The global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025. Market Analysis an…- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 抗糖尿病治療薬の世界市場（～2026年） The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for…
- 抗炎症薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-inflammatory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-inflammatory Dru…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…